996 related articles for article (PubMed ID: 29981863)
21. The Dx-AF study: a prospective, multicenter, randomized controlled trial comparing VDD-ICD to VVI-ICD in detecting sub-clinical atrial fibrillation in defibrillator patients.
Shurrab M; Janmohamed A; Sarrazin JF; Ayala-Paredes F; Sturmer M; Williams R; Toal S; Lane C; Thorpe KE; Healey JS; Crystal E
J Interv Card Electrophysiol; 2017 Oct; 50(1):57-63. PubMed ID: 28752228
[TBL] [Abstract][Full Text] [Related]
22. Wearable and implantable diagnostic monitors in early assessment of atrial tachyarrhythmia burden.
Healey JS; Wong J
Europace; 2019 Mar; 21(3):377-382. PubMed ID: 30418608
[TBL] [Abstract][Full Text] [Related]
23. Pacemaker-detected atrial fibrillation in patients with pacemakers: prevalence, predictors, and current use of oral anticoagulation.
Healey JS; Martin JL; Duncan A; Connolly SJ; Ha AH; Morillo CA; Nair GM; Eikelboom J; Divakaramenon S; Dokainish H
Can J Cardiol; 2013 Feb; 29(2):224-8. PubMed ID: 23142343
[TBL] [Abstract][Full Text] [Related]
24. Clinical Implications of Brief Device-Detected Atrial Tachyarrhythmias in a Cardiac Rhythm Management Device Population: Results from the Registry of Atrial Tachycardia and Atrial Fibrillation Episodes.
Swiryn S; Orlov MV; Benditt DG; DiMarco JP; Lloyd-Jones DM; Karst E; Qu F; Slawsky MT; Turkel M; Waldo AL;
Circulation; 2016 Oct; 134(16):1130-1140. PubMed ID: 27754946
[TBL] [Abstract][Full Text] [Related]
25. Dual antiplatelet therapy versus oral anticoagulation plus dual antiplatelet therapy in patients with atrial fibrillation and low-to-moderate thromboembolic risk undergoing coronary stenting: design of the MUSICA-2 randomized trial.
Sambola A; Montoro JB; Del Blanco BG; Llavero N; Barrabés JA; Alfonso F; Bueno H; Cequier A; Serra A; Zueco J; Sabaté M; Rodríguez-Leor O; García-Dorado D
Am Heart J; 2013 Oct; 166(4):669-75. PubMed ID: 24093846
[TBL] [Abstract][Full Text] [Related]
26. Continuous rhythm monitoring-guided anticoagulation after atrial fibrillation ablation.
Pothineni NVK; Amankwah N; Santangeli P; Schaller RD; Supple GE; Deo R; Nazarian S; Garcia FC; Dixit S; Callans DJ; Marchlinski FE; Frankel DS
J Cardiovasc Electrophysiol; 2021 Feb; 32(2):345-353. PubMed ID: 33382500
[TBL] [Abstract][Full Text] [Related]
27. Temporal Trends in the Use and Comparative Effectiveness of Direct Oral Anticoagulant Agents Versus Warfarin for Nonvalvular Atrial Fibrillation: A Canadian Population-Based Study.
Yu AYX; Malo S; Svenson LW; Wilton SB; Hill MD
J Am Heart Assoc; 2017 Oct; 6(11):. PubMed ID: 29080863
[TBL] [Abstract][Full Text] [Related]
28. Role of cardiac electronic implantable device in the stratification and management of embolic risk of silent atrial fibrillation: are all atrial fibrillations created equal?
Di Cori A; Lilli A; Zucchelli G; Zaca V
Expert Rev Cardiovasc Ther; 2018 Mar; 16(3):175-181. PubMed ID: 29431527
[TBL] [Abstract][Full Text] [Related]
29. Randomized trial of atrial arrhythmia monitoring to guide anticoagulation in patients with implanted defibrillator and cardiac resynchronization devices.
Martin DT; Bersohn MM; Waldo AL; Wathen MS; Choucair WK; Lip GY; Ip J; Holcomb R; Akar JG; Halperin JL;
Eur Heart J; 2015 Jul; 36(26):1660-8. PubMed ID: 25908774
[TBL] [Abstract][Full Text] [Related]
30. Improving thromboprophylaxis using atrial fibrillation diagnostic capabilities in implantable cardioverter-defibrillators: the multicentre Italian ANGELS of AF Project.
Boriani G; Santini M; Lunati M; Gasparini M; Proclemer A; Landolina M; Padeletti L; Botto GL; Capucci A; Bianchi S; Biffi M; Ricci RP; Vimercati M; Grammatico A; Lip GY;
Circ Cardiovasc Qual Outcomes; 2012 Mar; 5(2):182-8. PubMed ID: 22373906
[TBL] [Abstract][Full Text] [Related]
31. Stroke and thromboembolism prevention in atrial fibrillation.
Jame S; Barnes G
Heart; 2020 Jan; 106(1):10-17. PubMed ID: 31533990
[TBL] [Abstract][Full Text] [Related]
32. Device-detected atrial fibrillation in a large remote-monitored cohort: implications for anticoagulation and need for new pathways of service delivery.
O'Shea CJ; Brooks AG; Middeldorp ME; Harper C; Hendriks JM; Russo AM; Freeman JV; Gopinathannair R; Varma N; Deering TF; Campbell K; Sanders P
J Interv Card Electrophysiol; 2023 Oct; 66(7):1659-1668. PubMed ID: 36735111
[TBL] [Abstract][Full Text] [Related]
33. Estimating the incidence of atrial fibrillation in single-chamber implantable cardioverter defibrillator patients.
Zweibel S; Cronin EM; Schloss EJ; Auricchio A; Kurita T; Sterns LD; Gerritse B; Lexcen DR; Cheng A
Pacing Clin Electrophysiol; 2019 Feb; 42(2):132-138. PubMed ID: 30478983
[TBL] [Abstract][Full Text] [Related]
34. Efficacy and safety of percutaneous left atrial appendage closure to prevent thromboembolic events in atrial fibrillation patients with high stroke and bleeding risk.
Seeger J; Bothner C; Dahme T; Gonska B; Scharnbeck D; Markovic S; Rottbauer W; Wöhrle J
Clin Res Cardiol; 2016 Mar; 105(3):225-9. PubMed ID: 26318322
[TBL] [Abstract][Full Text] [Related]
35. When is Device-Detected Atrial Fibrillation Actionable?
Wasserlauf J; Passman RS
Card Electrophysiol Clin; 2018 Mar; 10(1):75-85. PubMed ID: 29428144
[TBL] [Abstract][Full Text] [Related]
36. Disease management: atrial fibrillation and home monitoring.
Ricci RP
Europace; 2013 Jun; 15 Suppl 1():i35-i39. PubMed ID: 23737228
[TBL] [Abstract][Full Text] [Related]
37. Underuse of Anticoagulation in Older Patients with Atrial Fibrillation and CHADS
Henrard S; Vandenabeele C; Marien S; Boland B; Dalleur O
Drugs Aging; 2017 Nov; 34(11):841-850. PubMed ID: 29086350
[TBL] [Abstract][Full Text] [Related]
38. Periprocedural anticoagulation during left atrial ablation: interrupted and uninterrupted vitamin K-antagonists or uninterrupted novel anticoagulants.
Brinkmeier-Theofanopoulou M; Tzamalis P; Wehrkamp-Richter S; Radzewitz A; Merkel M; Schymik G; van Mark G; Bramlage P; Schmitt C; Luik A
BMC Cardiovasc Disord; 2018 Apr; 18(1):71. PubMed ID: 29703158
[TBL] [Abstract][Full Text] [Related]
39. [Atrial fibrillation prevalence and treatment with oral anticoagulation in patients with permanent pacemakers].
Arce M; Femenía F; Palazzolo J; Trucco E; Rodriguez C; Baranchuk A
Invest Clin; 2011 Mar; 52(1):58-68. PubMed ID: 21614814
[TBL] [Abstract][Full Text] [Related]
40. Probing oral anticoagulation in patients with atrial high rate episodes: Rationale and design of the Non-vitamin K antagonist Oral anticoagulants in patients with Atrial High rate episodes (NOAH-AFNET 6) trial.
Kirchhof P; Blank BF; Calvert M; Camm AJ; Chlouverakis G; Diener HC; Goette A; Huening A; Lip GYH; Simantirakis E; Vardas P
Am Heart J; 2017 Aug; 190():12-18. PubMed ID: 28760205
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
